NasdaqGS - Delayed Quote • USD
Regeneron Pharmaceuticals, Inc. (REGN)
At close: April 24 at 4:00 PM EDT
After hours: April 24 at 4:43 PM EDT
Contract Name | Last Trade Date (EDT) | Expire Date | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility |
---|---|---|---|---|---|---|---|---|---|---|
REGN240621C00600000 | 12/15/2023 4:44 PM | 2024-06-21 | 284.52 | 344.00 | 353.20 | 0.00 | 0.00% | 5 | 9 | 126.00% |
REGN250117C00600000 | 6/28/2023 2:05 PM | 2025-01-17 | 176.87 | 210.30 | 218.00 | 0.00 | 0.00% | 1 | 3 | 0.00% |
REGN251219C00600000 | 4/18/2024 1:30 PM | 2025-12-19 | 371.10 | 369.00 | 378.00 | 0.00 | 0.00% | 2 | 5 | 49.57% |
Contract Name | Last Trade Date (EDT) | Expire Date | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility |
---|---|---|---|---|---|---|---|---|---|---|
REGN240517P00600000 | 4/8/2024 1:43 PM | 2024-05-17 | 0.25 | 0.00 | 4.30 | 0.00 | 0.00% | 2 | 23 | 89.55% |
REGN240621P00600000 | 4/18/2024 7:54 PM | 2024-06-21 | 3.43 | 0.00 | 4.80 | 0.00 | 0.00% | 1 | 339 | 57.51% |
REGN240816P00600000 | 4/11/2024 7:29 PM | 2024-08-16 | 2.84 | 0.00 | 3.60 | 0.00 | 0.00% | 5 | 12 | 44.31% |
REGN241115P00600000 | 3/22/2024 1:30 PM | 2024-11-15 | 2.50 | 0.10 | 8.20 | 0.00 | 0.00% | 4 | 13 | 39.69% |
REGN250117P00600000 | 4/19/2024 3:22 PM | 2025-01-17 | 7.40 | 1.50 | 8.70 | 0.00 | 0.00% | 2 | 50 | 35.23% |
REGN250620P00600000 | 1/8/2024 5:18 PM | 2025-06-20 | 17.20 | 6.90 | 16.00 | 0.00 | 0.00% | - | 4 | 33.22% |
REGN251219P00600000 | 3/25/2024 1:42 PM | 2025-12-19 | 11.30 | 0.00 | 0.00 | 0.00 | 0.00% | 2 | 126 | 6.25% |
REGN260116P00600000 | 1/29/2024 6:34 PM | 2026-01-16 | 16.45 | 10.60 | 16.90 | 0.00 | 0.00% | 6 | 10 | 27.60% |
Related Tickers
VRTX Vertex Pharmaceuticals Incorporated
400.76
-1.02%
MDGL Madrigal Pharmaceuticals, Inc.
204.65
-6.29%
ALNY Alnylam Pharmaceuticals, Inc.
143.80
-1.55%
BNTX BioNTech SE
88.09
-0.45%
INCY Incyte Corporation
51.74
+0.17%
CRSP CRISPR Therapeutics AG
55.65
-1.35%
MRNA Moderna, Inc.
108.85
+0.89%
NVO Novo Nordisk A/S
126.16
-1.93%
BHVN Biohaven Ltd.
38.72
-2.25%
VKTX Viking Therapeutics, Inc.
65.07
+0.22%